Bayer to Expand Into Molecular Imaging With Acquisition of Innovative Pan-Amyloid Radiotracers From Attralus

Bayer, a leading company in key areas of radiology and cardiology, and Attralus, Inc. (Attralus), a clinical stage biopharmaceutical company focused on developing medicines and diagnostics for ...
EurekAlert!

Dual-mode optical imaging system offers new noninvasive approach to skin cancer diagnosis

Line-field confocal optical coherence tomography (LC-OCT) captures high-resolution images of skin tissue at the cellular level, and then confocal Raman microspectroscopy analyzes the chemical makeup ...
Business Wire

Portable Diagnostic Imaging Business Research Report 2024-2030: Advances in AI-Driven Diagnostic Imaging Propel Growth in Portable Devices with Real-Time Image Analysis and ...

DUBLIN--(BUSINESS WIRE)--The "Portable Diagnostic Imaging - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Portable Diagnostic Imaging was ...
Pharmabiz

Bayer to acquire AT-01 & AT-05, investigational molecular imaging agents for the diagnosis of cardiac amyloidosis from Attralus

Bayer to acquire AT-01 & AT-05, investigational molecular imaging agents for the diagnosis of cardiac amyloidosis from Attralus: Berlin, Germany Wednesday, January 14, 2026, 11:00 ...
pv magazine International

Imaging tech to analyze sub-cells in tandem and triple junction PV devices

A team at Fraunhofer ISE has created new imaging methods to measure losses in individual sub-cells of multi-junction solar cells based on perovskite-silicon and perovskite-perovskite-silicon ...